Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge

Re-challenge with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) has been suggested to potentially improve survival in certain populations of patients with advanced lung cancer, but predictive markers for the success of EGFR-TKI re-challenge have not been identified. The pres...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Nakamura, Tomomi, Watanabe, Naomi, Sato, Akemi, Komiya, Kazutoshi, Umeguchi, Hitomi, Hosomi, Toshiya, Hirai, Mitsuharu, Sueoka, Eisaburo, Kimura, Shinya, Sueoka-Aragane, Naoko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2017
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452929/
https://ncbi.nlm.nih.gov/pubmed/28588734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6085
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller